Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7180
+0.0180 (2.57%)
At close: Aug 13, 2025, 4:00 PM
0.6800
-0.0380 (-5.29%)
Pre-market: Aug 14, 2025, 8:37 AM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $5.34 million as of August 14, 2025. Its market cap has increased by 1.44% in one year.
Market Cap
5.34M
Enterprise Value
3.21K
1-Year Change
1.44%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $5.34M, a decrease of -91.81%. That is a compound annual growth rate of -47.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 5.21M | 30.61% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |